NYSE monitoring KV after annual report delay - St. Louis Business Journal:

stelauguqdinec.blogspot.com
If the annual report is not filer withinsix months, the NYSE will then determins whether to give the company an additional six-month KV said Monday. The NYSE could commenc delisting procedures at any time during this KV said. The Mo.-based pharmaceutical company of its annual reportf due to an internal investigationn into management misconduct but said it expects matterw to be resolved by the endof July. Aftef halting drug production and shipments andrecallingv painkillers, KV for the fiscal year that ended March 31.
KV said it anticipatexs the costs related to the production stoppage and recalls will hurt fiscal year resultsby $140 million to $150 Late last year, KV and recalled drugs following problemsa with manufacturing, including the production of oversizedx tablets. In March, KV said it with the that outlined a series of measured that will permit KV and its subsidiaries to resumw manufacturingand distribution.